Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 62 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 9505766

    Kinase inhibitors

    The Regents of the University of California · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted
  2. US 9505719

    Synthesis and use of kinase inhibitors

    VERASTEM, INC. · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted
  3. US 9504736

    Administration of serine protease inhibitors to the stomach

    The Regents of the University of California · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted
  4. US 9499495

    Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways

    Asana BioSciences, LLC · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  5. US 9499487

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  6. US 9498471

    Use of CDK9 inhibitors to reduce cartilage degradation

    The Regents of the University of California · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  7. US 9498529

    Methods for treating or preventing influenza virus infection by administering a serine protease inhibitor

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  8. US 9499497

    Compounds useful as inhibitors of indoleamine 2,3-dioxygenase

    Vertex Pharmaceuticals Incorporated · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  9. US 9499821

    Preventing or treating viral infection using an inhibitor of the LSD1 protein, a MAO inhibitor or an inhibitor of LSD1 and a MAO inhibitor

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  10. US 9487555

    Prodrug of an ice inhibitor

    Vertex Pharmaceuticals Incorporated · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  11. US 9486422

    Small molecule inhibitors of Mcl-1 and the uses of thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  12. US 9487522

    SSH-2 (slingshot-2) inhibitors and methods for making and using them

    The Regents of the University of California · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  13. US 9487514

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  14. US 9475839

    Peptide-based inhibitor of interleukin-10 or interferon-gamma signaling

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted
  15. US 9475822

    Substituted 2- amidoquinazol-4-ones as matrix metalloproteinase-13 inhibitors

    Takeda Pharmaceutical Company Limited · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted
  16. US 9468649

    Methods of treating epilepsy with transforming growth factor beta inhibitors

    The Regents of the University of California · Granted Oct 18, 2016 · Expires Oct 13, 2036

    granted
  17. PT 2481410

    NITROCATECHOL DERIVATES AS COMT INHIBITORS ADMINISTERED WITH A SPECIFIC DOSAGE REGIME

    BIAL-PORTELA & Cª S A [PT] · Granted Oct 18, 2016 · Expires Oct 13, 2036

    granted
  18. US 9453019

    Linked purine pterin HPPK inhibitors useful as antibacterial agents

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 27, 2016 · Expires Sep 22, 2036

    granted
  19. US 9453028

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Sep 27, 2016 · Expires Sep 22, 2036

    granted
  20. US 9447047

    Inhibitors of protein phosphatase-1 and uses thereof

    The Board of Regents of the University of Texas System · Granted Sep 20, 2016 · Expires Sep 15, 2036

    granted
  21. US 9446139

    Polymer-based compositions and conjugates of HIV entry inhibitors

    Nektar Therapeutics · Granted Sep 20, 2016 · Expires Sep 15, 2036

    granted
  22. US 9428457

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted
  23. US 9422340

    Macrocyclic compounds useful as inhibitors of histone deacetylases

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted
  24. US 9422271

    Pyrimidine compounds as tuberculosis inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted